David Kelly, JPMorgan, and Thomas Costerg, Standard Chartered Bank, give their take on the current market conditions and Fed action.» Read More
Futures moved lower Wednesday following an unexpected drop in durable goods orders and as ongoing worries over a possible U.S. debt default weighed on sentiment.
Dunkin' Brands' IPO pricing at $19 a share—well above the range set by underwriters—was the result of the “unbelievable buzz” around the company, its CEO told CNBC Wednesday "This brand is unbelievable and has an unbelievable buzz now
Washington's political paralysis around critical debt and budgetary issues will most certainly weigh on financial markets Wednesday.
To sell or not to sell Netflix? "You know what, in a curious twist on Shakespeare, that is not the question," says Mad Money host Jim Cramer.
Core Labs has pulled back after reporting a solid quarter, with Mad Money host Jim Cramer.
You say the name of a stock, and Mad Money's Jim Cramer tells you whether to buy or sell.
Plenty of stocks are defying the gravitational pull of Washington, especially the stocks of companies that have reported fantastic results, says Mad Money host Jim Cramer. Patrick Doyle, Domino's Pizza president & CEO weighs in.
Con Ed is about as secure as it gets, the only large cap utility with no power generation assets, says Mad Money host Jim Cramer.
U.S. politicians, in the process of kicking the proverbial debt can down the road, are also giving the dollar a good swift kick.
Mad Money host Jim Cramer explains why the market did not crash today.
The Fast Money traders offer special CNBC.com-only advice on your investments.
Radioshack is well positioned to capture smartphone/tablet boom, says Anthony Scaramucci, Skybridge Capital.
Colin Gillis, of BGC Partners, explains why he has a sell on Amazon.
Stocks closed lower Tuesday in thin volume as investors continued to worry over the ongoing debt talks in Washington.
See what's happening, who's talking and what will be making headlines on Wednesday's Squawk on the Street.
That August 2 deadline just keeps approaching, and Washington seems no closer to a debt deal. Here's how to trade the impasse.
In the next 14 months, patents for the top 20 drugs in the U.S. are set to expire. Although makers of such top-selling drugs, such as Lipitor and Plavix, will no longer have a monopoly on these drug formulas, pharmaceutical stocks will be able to weather the loss of these patents, said two health-care analysts.
"There's an uneasy stability in the market. I don't think the politicians should take that as any type of green light to allow this to continue," says one bond pro.
Netflix was dropped kicked off its recent 52 week high perch today. Not much to complain about in the reported quarter. EPS beat nicely and revenue was in the range of guidance (although slightly below the Street). So why are traders so down on this today...and should you be concerned?
The Fast Money traders weigh in on Apple, JetBlue and Netflix, and a look at Amazon ahead of earnings, with Gene Munster, Piper Jaffray.